Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China
· Delayed Price · Currency is CNY 70.36
-0.32 (-0.45%)
Apr 29, 2026, 3:14 PM CST
SHE:300573 Revenue
Shenyang Xingqi Pharmaceutical had revenue of 683.34M CNY in the quarter ending March 31, 2026, with 27.45% growth. This brings the company's revenue in the last twelve months to 2.62B, up 23.03% year-over-year. In the year 2025, Shenyang Xingqi Pharmaceutical had annual revenue of 2.47B with 27.24% growth.
Revenue (ttm)
2.62B
Revenue Growth
+23.03%
P/S Ratio
6.62
Revenue / Employee
1.09M
Employees
2,396
Market Cap
17.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.47B | 529.46M | 27.24% |
| Dec 31, 2024 | 1.94B | 475.82M | 32.42% |
| Dec 31, 2023 | 1.47B | 217.71M | 17.42% |
| Jan 1, 2023 | 1.25B | 221.94M | 21.59% |
| Jan 1, 2022 | 1.03B | 339.23M | 49.26% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Winner Medical | 11.02B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.19B |
| Qingdao NovelBeam Technology | 630.18M |
| Autek China | 1.84B |
| Zhende Medical | 4.34B |
| Jiangsu Hualan New Pharmaceutical Material | 604.86M |
| iRay Group | 2.46B |
| Tofflon Science and Technology Group | 5.22B |